var data={"title":"Pasteurella infections","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pasteurella infections</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributors\" class=\"contributor contributor_credentials\">David J Weber, MD, MPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributors\" class=\"contributor contributor_credentials\">Allyson Bloom, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pasteurella-infections/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 30, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> are small gram-negative coccobacilli that are primarily commensals or pathogens of animals. However, these organisms can cause a variety of infections in humans, usually as a result of cat scratches, or cat or dog bites or licks.</p><p><em>Pasteurella</em> infections will be reviewed here. Other infections related to dog and cat bites or scratches are discussed separately. (See <a href=\"topic.htm?path=soft-tissue-infections-due-to-dog-and-cat-bites\" class=\"medical medical_review\">&quot;Soft tissue infections due to dog and cat bites&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;</a> and <a href=\"topic.htm?path=zoonoses-from-dogs\" class=\"medical medical_review\">&quot;Zoonoses from dogs&quot;</a> and <a href=\"topic.htm?path=zoonoses-from-cats\" class=\"medical medical_review\">&quot;Zoonoses from cats&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The members of the genus <em>Pasteurella</em> are small, nonmotile, nonspore-forming, gram-negative organisms. In Gram-stained specimens, they generally appear as a single bacillus, often with bipolar staining, but may also be seen in pairs or short chains (<a href=\"image.htm?imageKey=ID%2F70953\" class=\"graphic graphic_picture graphicRef70953 \">picture 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/1\" class=\"abstract_t\">1</a>].</p><p><em>Pasteurella</em> spp are aerobic, facultatively anaerobic, and grow well at 37&ordm;C on 5 percent sheep blood (the preferred culture medium), chocolate, or Mueller-Hinton agar; growth is uncommon on MacConkey's agar. Colonies of <em>Pasteurella</em> spp are 1 to 2 mm in diameter after 24 hours of growth at 37&ordm;C and are opaque and grayish [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/2\" class=\"abstract_t\">2</a>]. A slight greening underneath the colonies may be noted. Most strains recovered from clinical specimens are catalase, oxidase, indole, sucrose, and decarboxylate ornithine-positive. The indole-positive species exhibit a mouse-like odor. Media containing <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a>, <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=amikacin-drug-information\" class=\"drug drug_general\">amikacin</a> have been used to select for <em>Pasteurella</em> [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/1\" class=\"abstract_t\">1</a>]. Potential bacterial virulence factors include the capsule, lipopolysaccharide, sialidases, hyaluronidase, surface adhesins, iron acquisition proteins [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/3\" class=\"abstract_t\">3</a>], and the <em>Pasteurella multocida</em> toxin [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/4\" class=\"abstract_t\">4</a>]. </p><p>Human infections have been reported from <em>P. multocida</em> (the most common pathogen and type species for the genus, which includes <em>P. multocida </em>subsp <em>multocida</em>, <em>P. multocida</em> subsp <em>septica</em>, and <em>P. multocida</em> subsp <em>gallicida</em>), <em>Pasteurella</em> <em>canis</em>, <em>Pasteurella dagmatis</em>, and <em>Pasteurella stomatis</em> [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/2,5\" class=\"abstract_t\">2,5</a>]. All are associated with dogs and cats. <em>P. multocida</em> isolates are classified based on a combination of capsular polysaccharide serotyping, which distinguishes isolates into one of five capsular serogroups (ie, A, B, D, E, and F); serotypes A and D account for most human disease [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/6\" class=\"abstract_t\">6</a>]. Related species include <em>Pasteurella aerogenes</em>, <em>Pasteurella bettyae,</em> <em>Pasteurella caballi</em>, and <em>Pasteurella pneumotropica</em> [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/1\" class=\"abstract_t\">1</a>]. Polymerase chain reaction plus sequence-based ribotyping analysis using universal primers for the 16sRNA gene or rpoB gene sequencing have now superseded phenotypic methods for the identification, characterization, and differentiation of <em>P. multocida</em> and other <em>Pasteurella</em> spp [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/2,6\" class=\"abstract_t\">2,6</a>]. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry can also be used for accurate identification [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/2\" class=\"abstract_t\">2</a>]. The complete genome sequence of an avian clone of <em>P. multocida</em> [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/7\" class=\"abstract_t\">7</a>] and the type strain <em>P. multocida</em> subsp <em>multocida</em> ATCC 43137 have been determined [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/7\" class=\"abstract_t\">7</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H1662043210\"><span class=\"h2\">Animal hosts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> spp are found worldwide [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/3\" class=\"abstract_t\">3</a>]. <em>P. multocida</em> is a component of the normal upper respiratory tract flora of fowl and mammals. Cats and dogs have the highest carriage rate of <em>P. multocida</em> at 70 to 90 percent and 20 to 50 percent, respectively [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/8\" class=\"abstract_t\">8</a>]. Other <em>Pasteurella</em> spp can be found in the oral cavity of a variety of animals, including dogs (<em>P. canis</em>), cats and dogs (<em>P. dagmatis, P. stomatis</em>), pigs and hamsters (<em>P. aerogenes</em>), and horses (<em>P.</em> <em>caballi</em>). </p><p><em>Pasteurella</em> can cause a variety of diseases in animals, such as fowl cholera in domestic fowl, shipping fever in cattle (<em>P. multocida</em> is a cause of secondary infection following parainfluenza infection), hemorrhagic septicemia in cattle and lambs, fibrinous pneumonia in cattle, snuffles in rabbits, and other focal infections [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H781540124\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Wild and domestic animals are the main reservoirs for human infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/2,9\" class=\"abstract_t\">2,9</a>]. <em>Pasteurella</em> spp are the most frequent isolates from dog bites and cat scratches and bites (approximately 50 and 75 percent, respectively) [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/10-12\" class=\"abstract_t\">10-12</a>]. Human infection with <em>Pasteurella</em> also may result from bites of other felines (eg, tigers, lions, panthers, cougars), horses, pigs, rats, rabbits, and wolves. (See <a href=\"topic.htm?path=soft-tissue-infections-due-to-dog-and-cat-bites\" class=\"medical medical_review\">&quot;Soft tissue infections due to dog and cat bites&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;</a>.)</p><p>Although most human infections are caused by dog or cat bites, licks from these animals have also been associated with infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/13-15\" class=\"abstract_t\">13-15</a>]. Licking of distal areas of nonintact skin by cats and dogs have led to seeding of proximal prosthetic joints such as a total knee [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/16\" class=\"abstract_t\">16</a>] or hip [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/17\" class=\"abstract_t\">17</a>] arthroplasty. Kissing animals has been reported as the source in <em>Pasteurella</em> in several cases [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/18\" class=\"abstract_t\">18</a>]. Indirect transmission through fomites has also been suggested, as illustrated by cases of infants with severe <em>P. multocida</em> infections linked to contact with pet saliva from a pacifier or a sibling's finger [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/19,20\" class=\"abstract_t\">19,20</a>]. </p><p>Molecular analysis has documented animal-to-human transmission both by direct and indirect contact. <em>P. multocida</em> pneumonia in a 75-year-old woman was linked to her dog by pulsed-field electrophoresis analysis [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/21\" class=\"abstract_t\">21</a>]. Meningitis in an immunocompetent 25-year-old woman was linked to her dog by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/22\" class=\"abstract_t\">22</a>]. <em>P. multocida</em> subsp <em>septica</em> meningitis in a one-day-old boy was linked to the family cats by repetitive-sequence-based polymerase chain reaction [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/23\" class=\"abstract_t\">23</a>].</p><p>Human-to-human horizontal transmission has also been documented, including transmission via close contact with colonized individuals and transmission via contaminated blood products [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/24,25\" class=\"abstract_t\">24,25</a>]. Vertical transmission can occur via transplacental infection, endometritis, or genital tract colonization [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/20,26\" class=\"abstract_t\">20,26</a>]. </p><p class=\"headingAnchor\" id=\"H1765029466\"><span class=\"h2\">Risk factors for severe disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Severe infections can occur in previously healthy individuals. However, individuals with impaired host defenses or immunocompromising condition (including those with cirrhosis, hematologic malignancies, or solid organ transplantation) are at particular risk. Additionally, serious infections are more likely at the extremes of life (ie, in neonates [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/26\" class=\"abstract_t\">26</a>] or with advanced age [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"abstract_t\">27</a>]).</p><p>In a study that compared features of <em>P. multocida</em> infections with or without history of an animal bite, infection without a bite history was associated with severe comorbidity and immunocompromising condition, as well as more severe disease, including bacteremia, need for intensive care unit management, and mortality [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"abstract_t\">27</a>]. An immunocompromising condition has been reported to be a risk factor for hospitalization following a cat [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/28\" class=\"abstract_t\">28</a>] or dog bite [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/29\" class=\"abstract_t\">29</a>]. Comorbidities that increase the risk of particular <em>Pasteurella</em> infections include a prosthetic joint for septic arthritis, underlying lung disease for pneumonia, and peritoneal dialysis for peritonitis. </p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> can cause serious soft tissue infections and, less commonly, septic arthritis, osteomyelitis, sepsis, and meningitis, particularly in infants [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/30\" class=\"abstract_t\">30</a>] and other immunocompromised hosts [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/29,31\" class=\"abstract_t\">29,31</a>]. Infections with <em>P. multocida</em> can be divided into three categories (<a href=\"image.htm?imageKey=ID%2F64084\" class=\"graphic graphic_table graphicRef64084 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32\" class=\"abstract_t\">32</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cellulitis following animal bites or scratches; bites and scratches can also result in abscesses, necrotizing soft tissue infections, septic arthritis, and osteomyelitis</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Respiratory infections, usually in the setting of chronic pulmonary disease</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serious invasive infection often unrelated to animal bites, such as meningitis, intra-abdominal infection, endocarditis, or ocular infection</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Soft tissue infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical soft tissue infections with <em>P. multocida</em> usually occur after cat bites, cat scratches, or dog bites [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/12,14,32-34\" class=\"abstract_t\">12,14,32-34</a>], but may also occur following cat or dog licks of nonintact skin [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/13-15\" class=\"abstract_t\">13-15</a>]. <em>P. multocida</em> wound infections characteristically have a very rapid development of an intense inflammatory response. Most patients develop symptoms within 24 hours of the initial injury, and as early as three hours after a cat bite [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32\" class=\"abstract_t\">32</a>].</p><p>Pain and swelling are prominent. Purulent drainage is noted in about 40 percent of patients, lymphangitis in about 20 percent, and regional adenopathy in 10 percent. Cellulitis often occurs within 24 to 48 hours [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32,35,36\" class=\"abstract_t\">32,35,36</a>]. Necrotizing fasciitis may also occur [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/14,37\" class=\"abstract_t\">14,37</a>]. (See <a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">&quot;Necrotizing soft tissue infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Bone and joint infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>P. multocida</em> can cause septic arthritis <span class=\"nowrap\">and/or</span> osteomyelitis. Most cases of septic arthritis involve a cat or dog bite distal to the involved joint, without direct penetrating injury to the joint; approximately one-third of cases are not preceded by an animal bite or scratch. Septic arthritis without osteomyelitis most commonly involves a single joint, usually the knee. There is a predilection for involvement of prosthetic joints or joints damaged by rheumatoid arthritis or degenerative joint disease [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/16,38-40\" class=\"abstract_t\">16,38-40</a>]. More than 50 percent of patients who have septic arthritis also have altered host defenses from corticosteroids or alcoholism. (See <a href=\"topic.htm?path=septic-arthritis-in-adults\" class=\"medical medical_review\">&quot;Septic arthritis in adults&quot;</a>.)</p><p>Osteomyelitis results from either local extension of soft tissue infection or direct inoculation into the periosteum by the cat or dog bite. Osteomyelitis usually is preceded by significant wound infection and cellulitis. Cat bites are more likely to lead to bone infection than are dog bites, presumably because the small, sharp teeth of the cat more easily penetrate the periosteum. </p><p>The combination of <em>Pasteurella</em> septic arthritis and osteomyelitis almost always occurs after cat bites of the hand, resulting in osteomyelitis of the phalanx and interphalangeal arthritis.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Respiratory infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>P. multocida</em> can cause a variety of upper and lower respiratory tract infections including glossitis, pharyngitis, sinusitis, otitis media, mastoiditis, epiglottitis, tracheobronchitis, pneumonia, empyema, and lung abscess [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27,32,41-44\" class=\"abstract_t\">27,32,41-44</a>]. The majority of patients with <em>P. multocida</em> respiratory tract infections have underlying lung disease such as chronic obstructive lung disease or chronic bronchitis. </p><p>Pneumonia is the most common pleuropulmonary infection caused by <em>P. multocida</em>, with most cases occurring in older adults [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32,45\" class=\"abstract_t\">32,45</a>]. In one series of 108 patients with <em>Pasteurella</em> pleuropulmonary infection, 49 had pneumonia, 37 tracheobronchitis, 25 empyema, and 3 lung abscess [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/46\" class=\"abstract_t\">46</a>]. Bacteremia was found in 55 percent of the patients in whom blood cultures were obtained. The overall mortality in this series was 29 percent. An underlying disease was found in 93 percent of patients. </p><p>The clinical course of <em>Pasteurella</em> respiratory tract infections is nonspecific. Common symptoms include fever, malaise, dyspnea, and pleuritic chest pain [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32,41\" class=\"abstract_t\">32,41</a>]. Approximately two-thirds of patients have fever. The onset of the illness may be gradual or abrupt. In patients with pneumonia, chest examination often reveals localized findings such as dullness, rhonchi, or wheezes. The chest radiograph most commonly demonstrates lobar consolidation, but multilobar and diffuse infiltrates have been described.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Other invasive infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> spp can cause a variety of other serious invasive infections such as meningitis, bacteremia, endocarditis, and peritonitis. Sepsis and septic shock may result from <em>P. multocida</em> infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/47-49\" class=\"abstract_t\">47-49</a>] and present with purpura fulminans [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/50\" class=\"abstract_t\">50</a>]. Serious invasive infection has been reported after exposure to animals in the absence of a bite or a scratch [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/13,48,51-57\" class=\"abstract_t\">13,48,51-57</a>]. In addition, <em>P. multocida</em> can rarely be associated with in utero infection leading to fetal death [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/58\" class=\"abstract_t\">58</a>], acute suppurative thyroiditis [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/59\" class=\"abstract_t\">59</a>], and urinary tract infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/60\" class=\"abstract_t\">60</a>]. <em>P. multocida</em> infections of aortic <span class=\"nowrap\">and/or</span> femoral vascular grafts [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/61-63\" class=\"abstract_t\">61-63</a>] and hemodialysis grafts [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/64\" class=\"abstract_t\">64</a>] have been reported.</p><p>Most of the uncommon manifestations of <em>P. multocida</em> infection have been noted in case reports (<a href=\"image.htm?imageKey=ID%2F64084\" class=\"graphic graphic_table graphicRef64084 \">table 1</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Meningitis</strong> &mdash; <em>P. multocida</em> meningitis is a disease of the extremes of life [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/13,18,20,22,23,25,32,51-55,65,66\" class=\"abstract_t\">13,18,20,22,23,25,32,51-55,65,66</a>]. Fifty percent of cases have involved infants younger than one year of age, and 30 percent have involved adults older than 60 years [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32,53,67\" class=\"abstract_t\">32,53,67</a>]. Mechanisms by which <em>P. multocida</em> can cause central nervous system infection include direct inoculation with an animal bite (eg, a perforating bite to an infant's skull), contamination from contiguous infected wounds after trauma or neurosurgery, extension from an adjacent infected site by spread through lymphatics or veins, and bacteremic seeding of the meninges [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/67,68\" class=\"abstract_t\">67,68</a>].</p><p/><p class=\"bulletIndent1\">The cerebrospinal fluid (CSF) generally contains polymorphonuclear leukocytes with a low glucose and elevated protein, similar to other pyogenic infections. Gram stain of the CSF is positive in 80 percent of patients, but the organisms are frequently misidentified as <em>Haemophilus influenzae</em> or <em>Neisseria meningitidis</em>. (See <a href=\"topic.htm?path=gram-negative-bacillary-meningitis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Gram-negative bacillary meningitis: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Bacteremia</strong> &mdash; Bacteremia with <em>P. multocida</em> usually accompanies a localized infection, most commonly cellulitis. Bacteremia occurs in 25 to 50 percent of patients with pneumonia, meningitis, and septic arthritis due to <em>P. multocida</em>. However, it may also occur in the absence of a localized site of infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32,47\" class=\"abstract_t\">32,47</a>]. Many patients with bacteremia have evidence of a predisposing condition, such as significant liver dysfunction, diabetes mellitus, and solid organ transplantation [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/31,32,47,69-73\" class=\"abstract_t\">31,32,47,69-73</a>]. Nonetheless, sepsis and septic shock have also been described in previously healthy individuals [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/74,75\" class=\"abstract_t\">74,75</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Endocarditis</strong> &mdash; Endocarditis is a rare complication of <em>P. multocida</em> sepsis, with about 15 cases of <em>P. multocida</em> endocarditis reported [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/76,77\" class=\"abstract_t\">76,77</a>]. Infection may involve native or prosthetic valves.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Abdominal infections</strong> &mdash; Intra-abdominal infections caused by <em>P. multocida</em> include peritonitis and appendicitis [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/69,78-83\" class=\"abstract_t\">69,78-83</a>].</p><p/><p class=\"bulletIndent1\">Peritonitis due to <em>P. multocida</em>, especially in the setting of continuous ambulatory peritoneal dialysis, has been reported [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/78-81,84-86\" class=\"abstract_t\">78-81,84-86</a>]. In these cases, <em>P. multocida</em> was isolated along with more traditional intra-abdominal pathogens. Gram stain of the peritoneal fluid was negative in approximately one-half of the cases.</p><p/><p class=\"bulletIndent1\">Cats were the source of almost all peritoneal infections. In most of the cases associated with peritoneal dialysis (approximately two-thirds), the dialysis tubing had been punctured by the cat.</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H1978561459\"><span class=\"h2\">Clinical suspicion and evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> spp are the first organisms to consider in any patient who presents with a soft tissue infection following cat scratches, or cat or dog bites or licks. Such infections are characterized by rapid onset and an intense inflammatory response, similar to group A streptococcal (Streptococcus pyogenes) soft tissue infections. (See <a href=\"#H5\" class=\"local\">'Soft tissue infections'</a> above.)</p><p>Cat bite wounds tend to penetrate deeply, with a higher risk of associated osteomyelitis, tenosynovitis, and septic arthritis than dog bites. Additionally, septic arthritis in abnormal or prosthetic joints may follow distal animal bites or scratches. Clinicians should maintain a low threshold of suspicion for deeper infection in these scenarios. The possibility of <em>Pasteurella</em> spp should also be considered when patients with impaired host defenses (eg, liver insufficiency, diabetes mellitus, malignancy) present with serious infections (eg, pulmonary infections, meningitis, or spontaneous bacterial peritonitis) and a history of animal contact.</p><p>In these clinical infections, culture of the relevant clinical specimen is warranted. In particular, in wounds from animal scratches or bites, Gram stain and aerobic and anaerobic cultures from the depth of the puncture or laceration should be obtained, if possible. Further evaluation of animal bite wounds is discussed in detail elsewhere. (See <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites#H11\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;, section on 'Ancillary studies'</a> and <a href=\"topic.htm?path=soft-tissue-infections-due-to-dog-and-cat-bites#H4\" class=\"medical medical_review\">&quot;Soft tissue infections due to dog and cat bites&quot;, section on 'Clinical evaluation'</a>.) </p><p class=\"headingAnchor\" id=\"H1389461350\"><span class=\"h2\">Microbiological diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <em>P. multocida</em> infection is made by isolation of the organism in culture. The organism grows readily on sheep blood agar, which is routinely used in the clinical laboratory. (See <a href=\"#H2\" class=\"local\">'Microbiology'</a> above.)</p><p><em>P. multocida</em> may be isolated from respiratory tract samples of patients with pleuropulmonary disease. Because <em>P. multocida</em> respiratory tract infections are rare and have no distinctive characteristics, <em>P. multocida</em> may not be suspected as the infecting pathogen. In addition, <em>Pasteurella</em> may be mistaken for <em>H. influenzae</em>, <em>Moraxella catarrhalis</em>, <em>Neisseria</em> spp, or <em>Acinetobacter</em> spp on sputum Gram stain. The organism may also be misidentified initially on Gram stains of other deep culture specimen, such as cerebrospinal fluid. However, when recovered in culture, <em>Pasteurella</em> should be recognized as a serious pathogen and the patient treated accordingly. </p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specific treatment for suspected or known <em>P. multocida</em> infection should, in general, use one of the antibiotic options recommended by the Clinical and Laboratory Standards Institute (CLSI) for susceptibility testing, as described below [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/87\" class=\"abstract_t\">87</a>]. For monomicrobial infections, penicillin is the drug of choice. </p><p class=\"headingAnchor\" id=\"H4243343998\"><span class=\"h2\">Antibiotic options</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Pasteurella</em> spp, including <em>P. multocida</em>, are usually susceptible to a number of antibiotics (<a href=\"image.htm?imageKey=ID%2F70131\" class=\"graphic graphic_table graphicRef70131 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/88-93\" class=\"abstract_t\">88-93</a>]. These include penicillin, <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a>, <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a>, <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>, fluoroquinolones (eg, <a href=\"topic.htm?path=levofloxacin-drug-information\" class=\"drug drug_general\">levofloxacin</a>, <a href=\"topic.htm?path=moxifloxacin-drug-information\" class=\"drug drug_general\">moxifloxacin</a>), third- or later-generation cephalosporins (eg, <a href=\"topic.htm?path=cefpodoxime-drug-information\" class=\"drug drug_general\">cefpodoxime</a>, <a href=\"topic.htm?path=cefixime-drug-information\" class=\"drug drug_general\">cefixime</a>, <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>, <a href=\"topic.htm?path=ceftaroline-drug-information\" class=\"drug drug_general\">ceftaroline</a>), carbapenems (eg, <a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a>, <a href=\"topic.htm?path=meropenem-drug-information\" class=\"drug drug_general\">meropenem</a>, <a href=\"topic.htm?path=doripenem-drug-information\" class=\"drug drug_general\">doripenem</a>), and <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>. There are no clinical trials documenting or evaluating the efficacy of different antibiotic agents for <em>Pasteurella</em> infections, specifically. Recommendations on antibiotic selection are based on observational evidence from case reports and series and the expected in vitro susceptibility pattern of <em>Pasteurella</em> species. </p><p>For monomicrobial infections due to <em>Pasteurella</em>, penicillin is often the drug of choice because of its narrow spectrum, low cost, general safety, and extensive experience with its use. Other first-line agents include <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a>, and <a href=\"topic.htm?path=cefuroxime-drug-information\" class=\"drug drug_general\">cefuroxime</a>. Although penicillin resistance is uncommon, it has been described in a subset of cases. In a report of 44 patients with <em>P. multocida</em> infections cultured between 2000 and 2014, of the 32 isolates that had &beta;-lactamase testing reported, 16 percent were &beta;-lactamase-positive [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"abstract_t\">27</a>]. Presence of a &beta;-lactamase was not associated with the type or severity of infection [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"abstract_t\">27</a>]. </p><p>Clinical failures have been noted in patients treated with oral <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a>, semi-synthetic penicillins (eg, <a href=\"topic.htm?path=oxacillin-drug-information\" class=\"drug drug_general\">oxacillin</a>, <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a>), first-generation cephalosporins (eg, cephalothin, <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a>, <a href=\"topic.htm?path=cefadroxil-drug-information\" class=\"drug drug_general\">cefadroxil</a>), and <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>. These agents have poor in vitro activity against <em>P. multocida</em> and should be avoided. </p><p>For soft tissue bite wound infections, susceptibility testing is generally not necessary. However, in light of reports of beta-lactamase production, testing of isolates from normally sterile sources (blood cultures, deep tissue, implanted prosthetic devices) and respiratory specimens for beta-lactamase activity may be warranted, particularly in immunocompromised patients [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/87\" class=\"abstract_t\">87</a>]. Additional reasons to perform susceptibility testing include [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/94\" class=\"abstract_t\">94</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent infection</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical failure of initial antibiotic therapy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Allergy to or intolerance of the drugs of choice</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Possible resistance to a drug that is being considered for therapy</p><p/><p>When indicated, antibiotic susceptibility testing should follow the guidelines of the CLSI [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/87\" class=\"abstract_t\">87</a>]. <em>P. multocida</em> susceptibility break points have been provided for the following agents:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Penicillins (penicillin, <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a>, <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cephalosporins (<a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Quinolones (<a href=\"topic.htm?path=levofloxacin-drug-information\" class=\"drug drug_general\">levofloxacin</a>, <a href=\"topic.htm?path=moxifloxacin-drug-information\" class=\"drug drug_general\">moxifloxacin</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tetracyclines (<a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a>, <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Macrolides (<a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a>, <a href=\"topic.htm?path=azithromycin-drug-information\" class=\"drug drug_general\">azithromycin</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Others (<a href=\"topic.htm?path=chloramphenicol-drug-information\" class=\"drug drug_general\">chloramphenicol</a>, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a> [TMP-SMX])</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Animal bite wound infections</span></p><p class=\"headingAnchor\" id=\"H1272515987\"><span class=\"h3\">Empiric antimicrobial and general management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Empiric antimicrobial therapy, whether administered by mouth or intravenously, should be directed at the polymicrobial infection that frequently occurs after animal bites, including <em>Pasteurella</em> spp and also oral anaerobes, streptococci, <em>Capnocytophaga canimorsus</em>, and <em>Staphylococcus aureus</em>. We suggest <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a> for initial empiric therapy of animal-associated wounds for those who can take oral therapy. Intravenous therapy is warranted in patients who cannot tolerate or fail oral therapy, or who have evidence for sepsis, metastatic spread, or deeper infections (such as septic arthritis or osteomyelitis). We suggest <a href=\"topic.htm?path=ampicillin-and-sulbactam-drug-information\" class=\"drug drug_general\">ampicillin-sulbactam</a> for intravenous empiric therapy for patients with mild infection and agents with broader coverage (eg, <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a>, a carbapenem, or a third-generation cephalosporin with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a>) for patients with more severe infections. Doses and other potential regimens are listed in the tables (<a href=\"image.htm?imageKey=ID%2F75020\" class=\"graphic graphic_table graphicRef75020 \">table 3</a> and <a href=\"image.htm?imageKey=ID%2F63280\" class=\"graphic graphic_table graphicRef63280 \">table 4</a>) and discussed in detail elsewhere. (See <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites#H27\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;, section on 'Infected bites'</a> and <a href=\"topic.htm?path=soft-tissue-infections-due-to-dog-and-cat-bites#H8\" class=\"medical medical_review\">&quot;Soft tissue infections due to dog and cat bites&quot;, section on 'Antibiotic prophylaxis'</a>.)</p><p>Other general management of <em>P. multocida</em> soft tissue infection associated with an animal bite includes evaluation for complications (including neurovascular or other deep injury), irrigation of large wounds, and determination of the need for tetanus or rabies postexposure prophylaxis [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/33\" class=\"abstract_t\">33</a>]. These issues are also discussed in detail elsewhere. (See <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites#H16\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;, section on 'Initial management'</a> and <a href=\"topic.htm?path=tetanus\" class=\"medical medical_review\">&quot;Tetanus&quot;</a> and <a href=\"topic.htm?path=rabies-immune-globulin-and-vaccine\" class=\"medical medical_review\">&quot;Rabies immune globulin and vaccine&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Definitive therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Definitive antimicrobial therapy should be based upon the results of wound cultures. </p><p class=\"headingAnchor\" id=\"H776527746\"><span class=\"h4\">Skin and soft tissue infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most soft tissue infections following an animal bite are polymicrobial [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/10\" class=\"abstract_t\">10</a>], and the definitive antibiotic regimen should cover other pathogens that are isolated on wound culture in addition to <em>Pasteurella</em> (<a href=\"image.htm?imageKey=ID%2F75020\" class=\"graphic graphic_table graphicRef75020 \">table 3</a>). <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">Amoxicillin-clavulanate</a> generally is appropriate to complete therapy for soft tissue infections following an animal bite. Even if cultures cannot be acquired or <em>Pasteurella</em> is not isolated on culture, we still use a regimen that includes coverage against <em>Pasteurella</em>, and so avoid monotherapy with <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a>, <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, or macrolides. When <em>Pasteurella</em> is isolated, susceptibility testing is generally not necessary given the typical susceptibility pattern of the organism. However, because of reports of beta-lactamase-producing isolates, we favor beta-lactamase testing for high-risk populations (ie, immunocompromised hosts). If <em>Pasteurella</em> is the only pathogen isolated, treatment with penicillin VK (50 <span class=\"nowrap\">mg/kg</span> per day divided in three or four doses for children beyond the newborn period; maximum adult dose 500 mg per dose three or four times per day [total dose 2 g per day]) is appropriate if beta-lactamase production has not been identified. <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">Amoxicillin</a> (25 to 50 <span class=\"nowrap\">mg/kg</span> per day divided in three doses for children beyond the newborn period; 500 mg three times daily for adults) is also an effective agent, and for children who use oral suspensions of medications, its taste may be better tolerated. Amoxicillin-clavulanate is appropriate in the setting of beta-lactamase production. Options for penicillin-allergic patients are discussed elsewhere. (See <a href=\"#H655876106\" class=\"local\">'Penicillin-allergic patients'</a> below.)</p><p>Therapy for local infections is usually 7 to 10 days, and for more severe infections, 10 to 14 days [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/30\" class=\"abstract_t\">30</a>]. Wound drainage or debridement may be necessary. Most cases of <em>Pasteurella</em> soft tissue infection following an animal scratch or bite resolve with appropriate oral antibiotics and wound drainage, when indicated.</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h4\">Septic arthritis and osteomyelitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When <em>Pasteurella</em> is isolated in cases of septic arthritis or osteomyelitis, we favor susceptibility testing to evaluate for beta-lactamase production. If there is no beta-lactamase, these infections can be treated with high doses of parenteral antibiotics (eg, <a href=\"topic.htm?path=penicillin-g-intravenous-and-short-acting-intramuscular-drug-information\" class=\"drug drug_general\">penicillin G</a>, 3.5 to 4.0 million units every 4 hours for adults or 200,000 <span class=\"nowrap\">units/kg</span> per day in 4 to 6 divided doses for children, with a maximum daily dose of 24 million units). In the presence of beta-lactamase production or other coinfecting pathogens, <a href=\"topic.htm?path=ampicillin-and-sulbactam-drug-information\" class=\"drug drug_general\">ampicillin-sulbactam</a>, <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a>, broad-spectrum cephalosporins (eg, <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>), and quinolones (eg, <a href=\"topic.htm?path=levofloxacin-drug-information\" class=\"drug drug_general\">levofloxacin</a>) are other options. Options for penicillin-allergic patients are discussed elsewhere. (See <a href=\"#H655876106\" class=\"local\">'Penicillin-allergic patients'</a> below.)</p><p>Septic arthritis often warrants multiple aspirations or debridement of the joint for control of the infection. In prosthetic joint involvement, removal of the prosthesis is usually required for resolution. (See <a href=\"topic.htm?path=septic-arthritis-in-adults#H21\" class=\"medical medical_review\">&quot;Septic arthritis in adults&quot;, section on 'Joint drainage'</a> and <a href=\"topic.htm?path=prosthetic-joint-infection-treatment#H8190615\" class=\"medical medical_review\">&quot;Prosthetic joint infection: Treatment&quot;, section on 'Clinical approach'</a>.)</p><p>Antimicrobial therapy is generally continued for four to six weeks for bone and joint infections [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/30\" class=\"abstract_t\">30</a>]. In some cases, if clinically appropriate, an oral regimen can be used to complete the course following improvement on the initial parenteral regimen. This decision is similar to that for bone and joint infection in general and is discussed in detail elsewhere. (See <a href=\"topic.htm?path=hematogenous-osteomyelitis-in-children-management#H630071671\" class=\"medical medical_review\">&quot;Hematogenous osteomyelitis in children: Management&quot;, section on 'Switch to oral therapy'</a> and <a href=\"topic.htm?path=septic-arthritis-in-adults#H20\" class=\"medical medical_review\">&quot;Septic arthritis in adults&quot;, section on 'Duration of antibiotic therapy'</a> and <a href=\"topic.htm?path=bacterial-arthritis-treatment-and-outcome-in-infants-and-children#H2304422496\" class=\"medical medical_review\">&quot;Bacterial arthritis: Treatment and outcome in infants and children&quot;, section on 'Oral therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H388465722\"><span class=\"h2\">Other invasive infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most positive cultures of blood, deep tissues, or respiratory tract yield only <em>Pasteurella</em> in isolation [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"abstract_t\">27</a>]. We favor testing <em>Pasteurella</em> isolates from such sterile or respiratory sites for beta-lactamase production. For isolates that do not produce a beta-lactamase, high-dose intravenous penicillin can be used for therapy. Alternatives for beta-lactamase-producing infections include <a href=\"topic.htm?path=ampicillin-and-sulbactam-drug-information\" class=\"drug drug_general\">ampicillin-sulbactam</a>, <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a>, and broad-spectrum cephalosporins (eg, <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>). For patients with meningitis, antibiotic selection should also take into account penetration of the agent into the cerebrospinal fluid, and we typically recommend a third generation cephalosporin (eg, ceftriaxone). Options for penicillin-allergic patients are discussed elsewhere. (See <a href=\"#H655876106\" class=\"local\">'Penicillin-allergic patients'</a> below.)</p><p>Data on the management of these other <em>Pasteurella</em> infections are limited to case reports. Duration of therapy is generally the same as for other infections at the same site. For example, pneumonia is generally treated for five to seven days in the absence of bacteremia, and for at least 14 days in the setting of bacteremia. Gram-negative rod meningitis warrants 21 days of therapy and repeated lumbar puncture to ensure improvement. Success with six weeks of therapy has been reported with <em>Pasteurella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/76\" class=\"abstract_t\">76</a>]. Durations of therapy longer than those listed here may be warranted in the case of slow response or particularly severe disease. </p><p class=\"headingAnchor\" id=\"H655876106\"><span class=\"h2\">Penicillin-allergic patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Alternative regimens for patients with penicillin allergies depend on the history and type of allergy.</p><p>For patients with reactions to penicillin that are not immediate hypersensitivity reactions (ie, not hives or anaphylaxis) to penicillin, broad spectrum cephalosporins (eg, <a href=\"topic.htm?path=cefixime-drug-information\" class=\"drug drug_general\">cefixime</a> or <a href=\"topic.htm?path=cefpodoxime-drug-information\" class=\"drug drug_general\">cefpodoxime</a> for oral therapy and <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> for parenteral therapy) are alternatives. These drugs are active against <em>Pasteurella</em> species in vitro, but there is limited clinical experience using them for the treatment of <em>Pasteurella</em> [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/30\" class=\"abstract_t\">30</a>]. </p><p>For patients with a history of immediate hypersensitivity reactions to penicillin, the clinical approach to deciding on the use of cephalosporins or carbapenems is discussed in detail elsewhere. (See <a href=\"topic.htm?path=allergy-evaluation-for-immediate-penicillin-allergy-skin-test-based-diagnostic-strategies-and-cross-reactivity-with-other-beta-lactam-antibiotics\" class=\"medical medical_review\">&quot;Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics&quot;</a>.)</p><p>Options include using cephalosporins or carbapenems with a graded challenge (ie, starting at a very low dose and administering a 10-fold increased dose at intervals until the therapeutic dose is reached) or after desensitization to the chosen agent with the assistance of an allergy specialist. <em>P. multocida</em> has been reported to be highly susceptible to carbapenems (<a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a>, <a href=\"topic.htm?path=meropenem-drug-information\" class=\"drug drug_general\">meropenem</a>, <a href=\"topic.htm?path=ertapenem-drug-information\" class=\"drug drug_general\">ertapenem</a>) [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/88,90,93\" class=\"abstract_t\">88,90,93</a>], but there is limited experience using these agents. Otherwise, non-beta-lactam alternatives that typically have in vitro activity against <em>Pasteurella</em> include <a href=\"topic.htm?path=aztreonam-drug-information\" class=\"drug drug_general\">aztreonam</a>, quinolones (eg, <a href=\"topic.htm?path=levofloxacin-drug-information\" class=\"drug drug_general\">levofloxacin</a> or <a href=\"topic.htm?path=moxifloxacin-drug-information\" class=\"drug drug_general\">moxifloxacin</a>), <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, and <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prognosis for <em>Pasteurella</em> infections depends upon the site of infection and underlying medical conditions.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most soft tissues infections resolve with appropriate oral antibiotics and wound drainage, when indicated.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Approximately 50 percent of patients with osteomyelitis experience slow healing, nonunion, joint fusion, limitations of motion, or residual deformity.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Functional outcome of <em>P. multocida</em> infections of the hand is poor [<a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/95\" class=\"abstract_t\">95</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mortality in <em>Pasteurella</em> meningitis, bacteremia, and endocarditis are approximately 25 percent, 30 percent, and 30 percent, respectively.</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topic (see <a href=\"topic.htm?path=animal-and-human-bites-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Animal and human bites (Beyond the Basics)&quot;</a>) </p><p/><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Pasteurella</em> are small Gram-negative coccobacilli that can cause a variety of infections in humans, usually as a result of cat scratches, or cat or dog bites or licks. <em>Pasteurella multocida</em> is the most common pathogenic species. Severe infections can occur in previously healthy individuals. However, individuals with immunocompromising conditions (including those with cirrhosis, hematologic malignancies, and solid organ transplantation) are at particular risk. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Pasteurella</em> wound infections are characterized by the rapid development of an intense inflammatory response within 24 hours of the initial injury. Pain and swelling are prominent. Purulent drainage, lymphangitis, and regional lymphadenopathy also may be present. (See <a href=\"#H5\" class=\"local\">'Soft tissue infections'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Pasteurella</em> can also cause septic arthritis, usually at a joint distal to an animal bite, <span class=\"nowrap\">and/or</span> osteomyelitis, either from local extension of soft tissue infection or direct inoculation. Other invasive infections include pneumonia and other respiratory tract infections, meningitis, bacteremia, endocarditis, and peritonitis (<a href=\"image.htm?imageKey=ID%2F64084\" class=\"graphic graphic_table graphicRef64084 \">table 1</a>). (See <a href=\"#H6\" class=\"local\">'Bone and joint infections'</a> above and <a href=\"#H7\" class=\"local\">'Respiratory infections'</a> above and <a href=\"#H8\" class=\"local\">'Other invasive infections'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Pasteurella</em> infection should be considered in any patient who presents with a soft tissue infection following cat scratches, or cat or dog bites or licks. The diagnosis of <em>Pasteurella</em> infection is made by isolation of the organism in culture; the organism grows readily on sheep blood agar. (See <a href=\"#H13\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of <em>Pasteurella</em> soft tissue infection associated with an animal bite should begin with management of the bite wound. (See <a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites#H16\" class=\"medical medical_review\">&quot;Clinical manifestations and initial management of animal and human bites&quot;, section on 'Initial management'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Empiric antimicrobial therapy for infected animal wounds should include an agent active against <em>P. multocida</em> and other potential copathogens. For patients with mild infection, we suggest <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a> for oral therapy and <a href=\"topic.htm?path=ampicillin-and-sulbactam-drug-information\" class=\"drug drug_general\">ampicillin-sulbactam</a> for intravenous therapy (for those unable to tolerate oral therapy) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). For patients with more severe infection, we suggest empiric therapy with an agent with broader coverage (such as <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a>, a carbapenem, or a third-generation cephalosporin with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a>) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Doses and other potential regimens are listed in the tables (<a href=\"image.htm?imageKey=ID%2F75020\" class=\"graphic graphic_table graphicRef75020 \">table 3</a> and <a href=\"image.htm?imageKey=ID%2F63280\" class=\"graphic graphic_table graphicRef63280 \">table 4</a>). (See <a href=\"#H1272515987\" class=\"local\">'Empiric antimicrobial and general management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Definitive therapy for <em>Pasteurella</em> infection should be based upon the results of wound cultures. Susceptibility testing of isolates in soft tissue infections is generally not necessary. We perform beta-lactamase testing in infection in immunocompromised hosts and on isolates from normally sterile sources and respiratory specimens. (See <a href=\"#H4243343998\" class=\"local\">'Antibiotic options'</a> above and <a href=\"#H19\" class=\"local\">'Definitive therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For definitive therapy of monomicrobial infections due to <em>Pasteurella</em>, we suggest penicillin (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">Amoxicillin</a>, <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, beta-lactam-beta-lactamase inhibitor combinations, extended spectrum cephalosporins, quinolones, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>, and <a href=\"topic.htm?path=azithromycin-drug-information\" class=\"drug drug_general\">azithromycin</a> are potential alternatives (<a href=\"image.htm?imageKey=ID%2F70131\" class=\"graphic graphic_table graphicRef70131 \">table 2</a>). Semi-synthetic penicillins (eg, <a href=\"topic.htm?path=oxacillin-drug-information\" class=\"drug drug_general\">oxacillin</a> or <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a>), first-generation cephalosporins, <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, and <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> have poor activity and should be avoided. (See <a href=\"#H19\" class=\"local\">'Definitive therapy'</a> above and <a href=\"#H4243343998\" class=\"local\">'Antibiotic options'</a> above and <a href=\"#H655876106\" class=\"local\">'Penicillin-allergic patients'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H1237212630\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge William A Rutala, PhD, MPH, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">von Graevenitz A, Zbinden R, Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella, Pasteurella, and other fastidious or rarely encountered Gram-negative rods. In: Manual of Clinical Microbiology, 9th Ed, Murray PR (Ed), American Society for Microbiology, Washington, DC 2007. p.621.</li><li class=\"breakAll\">Zbinden R. Aggregatibacter, Capnocytophaga, Eikenella, Kingella, Pasteurella, and other fastidious or rarely encountered Gram-negative rods. In: Manual of Clinical Microbiology, 11th Ed, Jorgenesen JH, Pfaller MA (Eds), American Society for Microbiology, Washington, DC 2015. p.652.</li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/3\" class=\"nounderline abstract_t\">Wilkie IW, Harper M, Boyce JD, Adler B. Pasteurella multocida: diseases and pathogenesis. Curr Top Microbiol Immunol 2012; 361:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/4\" class=\"nounderline abstract_t\">Lax A. The Pasteurella multocida toxin: a new paradigm for the link between bacterial infection and cancer. Curr Top Microbiol Immunol 2012; 361:131.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/5\" class=\"nounderline abstract_t\">Donnio PY, Lerestif-Gautier AL, Avril JL. Characterization of Pasteurella spp. strains isolated from human infections. J Comp Pathol 2004; 130:137.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/6\" class=\"nounderline abstract_t\">Wilson BA, Ho M. Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev 2013; 26:631.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/7\" class=\"nounderline abstract_t\">May BJ, Zhang Q, Li LL, et al. Complete genomic sequence of Pasteurella multocida, Pm70. Proc Natl Acad Sci U S A 2001; 98:3460.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/8\" class=\"nounderline abstract_t\">Owen CR, Buker EO, Bell JF, Jellison WL. Pasteurella multocida in animals' mouths. Rocky Mt Med J 1968; 65:45.</a></li><li class=\"breakAll\">Acha PN, Szyfres B. Zoonoses and Communicable Diseases Common To Man and Animals, 3rd Ed, Pan American Health Organization, Washington, DC 2001. Vol 1, p.199.</li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/10\" class=\"nounderline abstract_t\">Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/11\" class=\"nounderline abstract_t\">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/12\" class=\"nounderline abstract_t\">Westling K, Farra A, Cars B, et al. Cat bite wound infections: a prospective clinical and microbiological study at three emergency wards in Stockholm, Sweden. J Infect 2006; 53:403.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/13\" class=\"nounderline abstract_t\">Perrin I, Blanc P, Karam T, Carbajal R. [Meningitis and osteitis caused by Pasteurella multocida in a three-month-old infant]. Arch Pediatr 2003; 10:439.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/14\" class=\"nounderline abstract_t\">Chang K, Siu LK, Chen YH, et al. Fatal Pasteurella multocida septicemia and necrotizing fasciitis related with wound licked by a domestic dog. Scand J Infect Dis 2007; 39:167.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/15\" class=\"nounderline abstract_t\">Chun ML, Buekers TE, Sood AK, Sorosky JI. Postoperative wound infection with Pasteurella multocida from a pet cat. Am J Obstet Gynecol 2003; 188:1115.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/16\" class=\"nounderline abstract_t\">Heym B, Jouve F, Lemoal M, et al. Pasteurella multocida infection of a total knee arthroplasty after a &quot;dog lick&quot;. Knee Surg Sports Traumatol Arthrosc 2006; 14:993.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/17\" class=\"nounderline abstract_t\">Lam PW, Page AV. Pasteurella multocida non-native joint infection after a dog lick: A case report describing a complicated two-stage revision and a comprehensive review of the literature. Can J Infect Dis Med Microbiol 2015; 26:212.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/18\" class=\"nounderline abstract_t\">Kawashima S, Matsukawa N, Ueki Y, et al. Pasteurella multocida meningitis caused by kissing animals: a case report and review of the literature. J Neurol 2010; 257:653.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/19\" class=\"nounderline abstract_t\">Bryant BJ, Conry-Cantilena C, Ahlgren A, et al. Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two cats. Transfusion 2007; 47:1984.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/20\" class=\"nounderline abstract_t\">Zaramella P, Zamorani E, Freato F, et al. Neonatal meningitis due to a vertical transmission of Pasteurella multocida. Pediatr Int 1999; 41:307.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/21\" class=\"nounderline abstract_t\">Miyoshi S, Hamada H, Miyoshi A, et al. Pasteurella multocida pneumonia: zoonotic transmission confirmed by molecular epidemiological analysis. Geriatr Gerontol Int 2012; 12:159.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/22\" class=\"nounderline abstract_t\">Bardou M, Honnorat E, Dubourg G, et al. Meningitis caused by Pasteurella multocida in a dog owner without a dog bite: clonal lineage identification by MALDI-TOF mass spectrometry. BMC Res Notes 2015; 8:626.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/23\" class=\"nounderline abstract_t\">Boyanton BL Jr, Freij BJ, Robinson-Dunn B, et al. Neonatal Pasteurella multocida subsp. septica Meningitis Traced to Household Cats: Molecular Linkage Analysis Using Repetitive-Sequence-Based PCR. J Clin Microbiol 2016; 54:230.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/24\" class=\"nounderline abstract_t\">Siahanidou T, Gika G, Skiathitou AV, et al. Pasteurella multocida Infection in a neonate: evidence for a human-to-human horizontal transmission. Pediatr Infect Dis J 2012; 31:536.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/25\" class=\"nounderline abstract_t\">Guillet C, Join-Lambert O, Carbonnelle E, et al. Pasteurella multocida sepsis and meningitis in 2-month-old twin infants after household exposure to a slaughtered sheep. Clin Infect Dis 2007; 45:e80.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/26\" class=\"nounderline abstract_t\">Nakwan N, Nakwan N, Atta T, Chokephaibulkit K. Neonatal pasteurellosis: a review of reported cases. Arch Dis Child Fetal Neonatal Ed 2009; 94:F373.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/27\" class=\"nounderline abstract_t\">Giordano A, Dincman T, Clyburn BE, et al. Clinical Features and Outcomes of Pasteurella multocida Infection. Medicine (Baltimore) 2015; 94:e1285.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/28\" class=\"nounderline abstract_t\">Babovic N, Cayci C, Carlsen BT. Cat bite infections of the hand: assessment of morbidity and predictors of severe infection. J Hand Surg Am 2014; 39:286.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/29\" class=\"nounderline abstract_t\">Rhea S, Weber DJ, Poole C, Cairns C. Risk factors for hospitalization after dog bite injury: a case-cohort study of emergency department visits. Acad Emerg Med 2014; 21:196.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Pasturella infections. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.596.</li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/31\" class=\"nounderline abstract_t\">Christenson ES, Ahmed HM, Durand CM. Pasteurella multocida infection in solid organ transplantation. Lancet Infect Dis 2015; 15:235.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/32\" class=\"nounderline abstract_t\">Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella multocida infections. Report of 34 cases and review of the literature. Medicine (Baltimore) 1984; 63:133.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/33\" class=\"nounderline abstract_t\">Weber DJ, Hansen AR. Infections resulting from animal bites. Infect Dis Clin North Am 1991; 5:663.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/34\" class=\"nounderline abstract_t\">Raval P, Khan W, Haddad B, Mahapatra AN. Bite injuries to the hand - review of the literature. Open Orthop J 2014; 8:204.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/35\" class=\"nounderline abstract_t\">Westling K, Bygdeman S, Engkvist O, Jorup-R&ouml;nstr&ouml;m C. Pasteurella multocida infection following cat bites in humans. J Infect 2000; 40:97.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/36\" class=\"nounderline abstract_t\">Nseir W, Giladi M, Moroz I, et al. A retrospective six-year national survey of P. multocida infections in Israel. Scand J Infect Dis 2009; 41:445.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/37\" class=\"nounderline abstract_t\">Hamamoto Y, Soejima Y, Ogasawara M, et al. Necrotizing fasciitis due to Pasteurella multocida infection. Dermatology 1995; 190:145.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/38\" class=\"nounderline abstract_t\">Heydemann J, Heydemann JS, Antony S. Acute infection of a total knee arthroplasty caused by Pasteurella multocida: a case report and a comprehensive review of the literature in the last 10 years. Int J Infect Dis 2010; 14 Suppl 3:e242.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/39\" class=\"nounderline abstract_t\">Ferguson KB, Bharadwaj R, MacDonald A, et al. Pasteurella multocida infected total knee arthroplasty: a case report and review of the literature. Ann R Coll Surg Engl 2014; 96:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/40\" class=\"nounderline abstract_t\">Ding DY, Orengo A, Alaia MJ, Zuckerman JD. Pasteurella multocida infection in a primary shoulder arthroplasty after cat scratch: case report and review of literature. J Shoulder Elbow Surg 2015; 24:e159.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/41\" class=\"nounderline abstract_t\">Klein NC, Cunha BA. Pasteurella multocida pneumonia. Semin Respir Infect 1997; 12:54.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/42\" class=\"nounderline abstract_t\">Byrd RP Jr, Roy TM. Pasteurella multocida respiratory infection: an important cat-associated zoonosis. Arch Intern Med 2003; 163:1239.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/43\" class=\"nounderline abstract_t\">Marinella MA. Community-acquired pneumonia due to Pasteurella multocida. Respir Care 2004; 49:1528.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/44\" class=\"nounderline abstract_t\">Harris PJ, Osswald MB. Pasteurella multocida epiglottitis: A review and report of a new case with associated chronic lymphocytic leukemia. Ear Nose Throat J 2010; 89:E4.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/45\" class=\"nounderline abstract_t\">Ferreira J, Treger K, Busey K. Pneumonia and disseminated bacteremia with Pasteurella multocida in the immune competent host: A case report and a review of the literature. Respir Med Case Rep 2015; 15:54.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/46\" class=\"nounderline abstract_t\">Kopita JM, Handshoe D, Kussin PS, Kelemen M. Cat germs! Pleuropulmonary pasteurella infection in an old man. N C Med J 1993; 54:308.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/47\" class=\"nounderline abstract_t\">Kimura R, Hayashi Y, Takeuchi T, et al. Pasteurella multocida septicemia caused by close contact with a domestic cat: case report and literature review. J Infect Chemother 2004; 10:250.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/48\" class=\"nounderline abstract_t\">Orsini J, Perez R, Llosa A, Araguez N. Non-zoonotic Pasteurella multocida Infection as a Cause of Septic Shock in a Patient with Liver Cirrhosis: A Case Report and Review of the Literature. J Glob Infect Dis 2013; 5:176.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/49\" class=\"nounderline abstract_t\">Oehler RL, Velez AP, Mizrachi M, et al. Bite-related and septic syndromes caused by cats and dogs. Lancet Infect Dis 2009; 9:439.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/50\" class=\"nounderline abstract_t\">Borges L, Oliveira N, C&aacute;ssio I, Costa H. Sepsis-induced purpura fulminans caused by Pasteurella multocida. BMJ Case Rep 2014; 2014.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/51\" class=\"nounderline abstract_t\">Wade T, Booy R, Teare EL, Kroll S. Pasteurella multocida meningitis in infancy - (a lick may be as bad as a bite). Eur J Pediatr 1999; 158:875.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/52\" class=\"nounderline abstract_t\">Hirsh D, Farrell K, Reilly C, Dobson S. Pasteurella multocida meningitis and cervical spine osteomyelitis in a neonate. Pediatr Infect Dis J 2004; 23:1063.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/53\" class=\"nounderline abstract_t\">Green BT, Ramsey KM, Nolan PE. Pasteurella multocida meningitis: case report and review of the last 11 y. Scand J Infect Dis 2002; 34:213.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/54\" class=\"nounderline abstract_t\">Thompson CM Jr, Pappu L, Levkoff AH, Herbert KH. Neonatal septicemia and meningitis due to Pasteurella multocida. Pediatr Infect Dis 1984; 3:559.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/55\" class=\"nounderline abstract_t\">Boerlin P, Siegrist HH, Burnens AP, et al. Molecular identification and epidemiological tracing of Pasteurella multocida meningitis in a baby. J Clin Microbiol 2000; 38:1235.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/56\" class=\"nounderline abstract_t\">Octavio J, Rosenberg W, Conte JE Jr. Surgical-wound infection with Pasteurella multocida from pet dogs. N Engl J Med 2001; 345:549.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/57\" class=\"nounderline abstract_t\">Cohen-Adam D, Marcus N, Scheuerman O, et al. Pasteurella multocida septicemia in a newborn without scratches, licks or bites. Isr Med Assoc J 2006; 8:657.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/58\" class=\"nounderline abstract_t\">Waldor M, Roberts D, Kazanjian P. In utero infection due to Pasteurella multocida in the first trimester of pregnancy: case report and review. Clin Infect Dis 1992; 14:497.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/59\" class=\"nounderline abstract_t\">McLaughlin SA, Smith SL, Meek SE. Acute suppurative thyroiditis caused by Pasteurella multocida and associated with thyrotoxicosis. Thyroid 2006; 16:307.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/60\" class=\"nounderline abstract_t\">Cortez JM, Imam AA, Ang JY. Pasteurella multocida urinary tract infection in a pediatric patient with end-stage renal disease. Pediatr Infect Dis J 2007; 26:183.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/61\" class=\"nounderline abstract_t\">Silberfein EJ, Lin PH, Bush RL, et al. Aortic endograft infection due to Pasteurella multocida following a rabbit bite. J Vasc Surg 2006; 43:393.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/62\" class=\"nounderline abstract_t\">Teso D, Williams S, Karmy-Jones R. Pasturella multicoda infection of an abdominal aortic endograft. World J Radiol 2013; 5:17.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/63\" class=\"nounderline abstract_t\">Fourreau F, M&eacute;cha&iuml; F, Brossier J, et al. Vascular graft infection due to Pasteurella multocida. Springerplus 2015; 4:824.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/64\" class=\"nounderline abstract_t\">Schneider JR, White GW, Dejesus EF. Pasteurella multocida-infected expanded polytetrafluoroethylene hemodialysis access graft. Ann Vasc Surg 2012; 26:1128.e15.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/65\" class=\"nounderline abstract_t\">Kobayaa H, Souki RR, Trust S, Domachowske JB. Pasteurella multocida meningitis in newborns after incidental animal exposure. Pediatr Infect Dis J 2009; 28:928.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/66\" class=\"nounderline abstract_t\">Guet-Revillet H, Levy C, Andriantahina I, et al. Paediatric epidemiology of Pasteurella multocida meningitis in France and review of the literature. Eur J Clin Microbiol Infect Dis 2013; 32:1111.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/67\" class=\"nounderline abstract_t\">O'Neill E, Moloney A, Hickey M. Pasteurella multocida meningitis: case report and review of the literature. J Infect 2005; 50:344.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/68\" class=\"nounderline abstract_t\">Klein DM, Cohen ME. Pasteurella multocida brain abscess following perforating cranial dog bite. J Pediatr 1978; 92:588.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/69\" class=\"nounderline abstract_t\">Ashley BD, Noone M, Dwarakanath AD, Malnick H. Fatal Pasteurella dagmatis peritonitis and septicaemia in a patient with cirrhosis: a case report and review of the literature. J Clin Pathol 2004; 57:210.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/70\" class=\"nounderline abstract_t\">Migliore E, Serraino C, Brignone C, et al. Pasteurella multocida infection in a cirrhotic patient: case report, microbiological aspects and a review of literature. Adv Med Sci 2009; 54:109.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/71\" class=\"nounderline abstract_t\">Tattevin P, Souala F, Gautier AL, et al. Diabetes in patients with pasteurellosis. Scand J Infect Dis 2005; 37:731.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/72\" class=\"nounderline abstract_t\">Olshtain-Pops K, Yinnon AM. Pasteurella multocida sepsis--should immunocompromised patients give up their pets? Isr Med Assoc J 2008; 10:648.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/73\" class=\"nounderline abstract_t\">Adler AC, Cestero C, Brown RB. Septic shock from Pasturella multocida following a cat bite: case report and review of literature. Conn Med 2011; 75:603.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/74\" class=\"nounderline abstract_t\">Ruiz-Irastorza G, Garea C, Alonso JJ, et al. Septic shock due to Pasteurella multocida subspecies multocida in a previously healthy woman. Clin Infect Dis 1995; 21:232.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/75\" class=\"nounderline abstract_t\">Fern&aacute;ndez-Valencia JA, Garc&iacute;a S, Prat S. Pasteurella multocida septic shock after a cat scratch in an elderly otherwise healthy woman: a case report. Am J Emerg Med 2008; 26:380.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/76\" class=\"nounderline abstract_t\">Nettles RE, Sexton DJ. Pasteurella multocida prosthetic valve endocarditis: case report and review. Clin Infect Dis 1997; 25:920.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/77\" class=\"nounderline abstract_t\">Fayad G, Modine T, Mokhtari S, et al. Pasteurella multocida aortic valve endocarditis: case report and literature review. J Heart Valve Dis 2003; 12:261.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/78\" class=\"nounderline abstract_t\">Cooke FJ, Kodjo A, Clutterbuck EJ, Bamford KB. A case of Pasteurella multocida peritoneal dialysis-associated peritonitis and review of the literature. Int J Infect Dis 2004; 8:171.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/79\" class=\"nounderline abstract_t\">Malik A, Al Aly Z, Mailey KS, Bastani B. Pasteurella multocida peritoneal dialysis-associated peritonitis: a report of two cases and review of the literature. J Nephrol 2005; 18:791.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/80\" class=\"nounderline abstract_t\">Loghman-Adham M. Pasteurella multocida peritonitis in patients undergoing peritoneal dialysis. Pediatr Nephrol 1997; 11:353.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/81\" class=\"nounderline abstract_t\">Mat O, Moenens F, Beauwens R, et al. Indolent Pasteurella multocida peritonitis in a CCPD patient. 25 years of &quot;cat-bite peritonitis&quot;: a review. Perit Dial Int 2005; 25:88.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/82\" class=\"nounderline abstract_t\">Tamaskar I, Ravakhah K. Spontaneous bacterial peritonitis with Pasteurella multocida in cirrhosis: case report and review of literature. South Med J 2004; 97:1113.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/83\" class=\"nounderline abstract_t\">Raffi F, David A, Mouzard A, et al. Pasteurella multocida appendiceal peritonitis: report of three cases and review of the literature. Pediatr Infect Dis 1986; 5:695.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/84\" class=\"nounderline abstract_t\">Rondon-Berrios H, Trevejo-Nunez GJ. Pets or pest: peritoneal dialysis-related peritonitis due to Pasteurella multocida. J Microbiol Immunol Infect 2010; 43:155.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/85\" class=\"nounderline abstract_t\">Sol PM, van de Kar NC, Schreuder MF. Cat induced Pasteurella multocida peritonitis in peritoneal dialysis: a case report and review of the literature. Int J Hyg Environ Health 2013; 216:211.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/86\" class=\"nounderline abstract_t\">Poliquin PG, Lagac&eacute;-Wiens P, Verrelli M, et al. Pasteurella species peritoneal dialysis-associated peritonitis: Household pets as a risk factor. Can J Infect Dis Med Microbiol 2015; 26:52.</a></li><li class=\"breakAll\">Clinical and Laboratory Standards Institute. Methods for antimicrobial dilutin and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved standard M45-A. Clinical and Laboratory Standards Institute; Wayne, PA 2006.</li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/88\" class=\"nounderline abstract_t\">Goldstein EJ, Citron DM, Merriam CV, et al. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. J Antimicrob Chemother 2001; 48:641.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/89\" class=\"nounderline abstract_t\">Goldstein EJ, Citron DM, Merriam CV, et al. In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species. Antimicrob Agents Chemother 2002; 46:3068.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/90\" class=\"nounderline abstract_t\">Goldstein EJ, Citron DM, Merriam CV, et al. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites. J Antimicrob Chemother 2002; 50:411.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/91\" class=\"nounderline abstract_t\">Citron DM, Warren YA, Fernandez HT, et al. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol 2005; 43:2485.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/92\" class=\"nounderline abstract_t\">Lion C, Conroy MC, Carpentier AM, Lozniewski A. Antimicrobial susceptibilities of Pasteurella strains isolated from humans. Int J Antimicrob Agents 2006; 27:290.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/93\" class=\"nounderline abstract_t\">Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL. Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolates. Antimicrob Agents Chemother 2012; 56:6319.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/94\" class=\"nounderline abstract_t\">Jorgensen JH, Hindler JF. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007; 44:280.</a></li><li><a href=\"https://www.uptodate.com/contents/pasteurella-infections/abstract/95\" class=\"nounderline abstract_t\">Lucas GL, Bartlett DH. Pasteurella multocida infection in the hand. Plast Reconstr Surg 1981; 67:49.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3129 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MICROBIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a><ul><li><a href=\"#H1662043210\" id=\"outline-link-H1662043210\">Animal hosts</a></li><li><a href=\"#H781540124\" id=\"outline-link-H781540124\">Transmission</a></li><li><a href=\"#H1765029466\" id=\"outline-link-H1765029466\">Risk factors for severe disease</a></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Soft tissue infections</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Bone and joint infections</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Respiratory infections</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Other invasive infections</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">DIAGNOSIS</a><ul><li><a href=\"#H1978561459\" id=\"outline-link-H1978561459\">Clinical suspicion and evaluation</a></li><li><a href=\"#H1389461350\" id=\"outline-link-H1389461350\">Microbiological diagnosis</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">TREATMENT</a><ul><li><a href=\"#H4243343998\" id=\"outline-link-H4243343998\">Antibiotic options</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Animal bite wound infections</a><ul><li><a href=\"#H1272515987\" id=\"outline-link-H1272515987\">- Empiric antimicrobial and general management</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Definitive therapy</a><ul><li><a href=\"#H776527746\" id=\"outline-link-H776527746\">Skin and soft tissue infection</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Septic arthritis and osteomyelitis</a></li></ul></li></ul></li><li><a href=\"#H388465722\" id=\"outline-link-H388465722\">Other invasive infections</a></li><li><a href=\"#H655876106\" id=\"outline-link-H655876106\">Penicillin-allergic patients</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">PROGNOSIS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H24\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H1237212630\" id=\"outline-link-H1237212630\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3129|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/70953\" class=\"graphic graphic_picture\">- Pasteurella multocida microscopy</a></li></ul></li><li><div id=\"ID/3129|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/64084\" class=\"graphic graphic_table\">- Sites of Pasteurella infection</a></li><li><a href=\"image.htm?imageKey=ID/70131\" class=\"graphic graphic_table\">- Rx of Pasteurella multocida</a></li><li><a href=\"image.htm?imageKey=ID/75020\" class=\"graphic graphic_table\">- Empiric oral antibiotics animal bites</a></li><li><a href=\"image.htm?imageKey=ID/63280\" class=\"graphic graphic_table\">- Empiric intravenous antibiotic therapy for animal bites</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=allergy-evaluation-for-immediate-penicillin-allergy-skin-test-based-diagnostic-strategies-and-cross-reactivity-with-other-beta-lactam-antibiotics\" class=\"medical medical_review\">Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-arthritis-treatment-and-outcome-in-infants-and-children\" class=\"medical medical_review\">Bacterial arthritis: Treatment and outcome in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-initial-management-of-animal-and-human-bites\" class=\"medical medical_review\">Clinical manifestations and initial management of animal and human bites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gram-negative-bacillary-meningitis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Gram-negative bacillary meningitis: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hematogenous-osteomyelitis-in-children-management\" class=\"medical medical_review\">Hematogenous osteomyelitis in children: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">Necrotizing soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=animal-and-human-bites-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Animal and human bites (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prosthetic-joint-infection-treatment\" class=\"medical medical_review\">Prosthetic joint infection: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rabies-immune-globulin-and-vaccine\" class=\"medical medical_review\">Rabies immune globulin and vaccine</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=septic-arthritis-in-adults\" class=\"medical medical_review\">Septic arthritis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=soft-tissue-infections-due-to-dog-and-cat-bites\" class=\"medical medical_review\">Soft tissue infections due to dog and cat bites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tetanus\" class=\"medical medical_review\">Tetanus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zoonoses-from-cats\" class=\"medical medical_review\">Zoonoses from cats</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zoonoses-from-dogs\" class=\"medical medical_review\">Zoonoses from dogs</a></li></ul></div></div>","javascript":null}